Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-147478
Filing Date
2009-07-10
Accepted
2009-07-10 16:50:32
Documents
7
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 731134
2 SECTION 302 PRESIDENT CERTIFICATION dex311.htm EX-31.1 7165
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7212
4 SECTION 302 COO CERTIFICATION dex313.htm EX-31.3 7186
5 SECTION 906 PRESIDENT CERTIFICATION dex321.htm EX-32.1 2501
6 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2583
7 SECTION 906 COO CERTIFICATION dex323.htm EX-32.3 2527
  Complete submission text file 0001193125-09-147478.txt   761748
Mailing Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607
Business Address 2203 N. LOIS AVENUE 9TH FLOOR TAMPA FL 33607 813-600-4088
Stem Cell Therapy International, Inc. (Filer) CIK: 0001360479 (see all company filings)

EIN.: 880374180 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51931 | Film No.: 09940506
SIC: 8071 Services-Medical Laboratories